Grazoprevir plus elbasvir in treatment-naive and treatment experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.

Roth D, Nelson DR, Bruchfeld A, et al. Grazoprevir plus elbasvir in treatment-naive and treatment experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study. Lancet. 2015;386(10003):1537-1545.

Publication Type:

Journal Article

Authors:

Roth, D.; David R. Nelson; Bruchfeld, A.; et, al

Source:

Lancet, Volume 386, Issue 10003, p.1537-1545 (2015)

Cited On:

Export Citation:
RIS Format
Top